Abstract
Abstract Pneumococcus contributes to nearly 50% of severe cases of pneumonia and pneumonia deaths. This article presents a literature review of the impact of the pneumococcal vaccines namely PCV7, PCV10 and PCV13 on community acquired pneumonia (CAP). It appears that the quantum of reduction of CAP is much better with PCV13 than PCV10 in several countries. However, inclusion of either vaccine in the national immunisation programme in developing countries has the potential to save 0.3–0.5 million deaths and 7–8 million episodes of severe CAP.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
